Atomo Diagnostics Limited
Atomo Diagnostics Limited
Your view on AT1.AX
Overview
What the company does, where it operates, and who runs it.
About Atomo Diagnostics Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John Michael Kelly
- Headquarters
- 3-5 George St, Leichhardt, NSW, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John Michael Kelly
- Headquarters
- 3-5 George St, Leichhardt, NSW, AU
Established in 2010 and based in Leichhardt, Australia, Atomo Diagnostics Limited is a global enterprise focused on the innovation and commercialization of medical devices.
The company provides swift-result diagnostic tools designed for various applications, including COVID-19 detection, HIV screening, pregnancy confirmation, and assessing respiratory conditions.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Atomo Diagnostics Limited. Starting points for Atomo Diagnostics Limited: beta 1.10 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Atomo Diagnostics Limited. Atomo Diagnostics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Atomo Diagnostics Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current YearFY Jun 2027 |
|---|---|
| Avg. estimate | AUD 0.00 |
| Low estimate | AUD 0.00 |
| High estimate | AUD 0.00 |
| No. of analysts | 0 |
| Year-ago EPS | −AUD 0.00 |
| Growth | +100.0% |
Revenue Estimate
| Revenue | Current YearFY Jun 2027 |
|---|---|
| Avg. estimate | AUD 31.96M |
| Low estimate | AUD 31.96M |
| High estimate | AUD 31.96M |
| No. of analysts | 1 |
| Year-ago revenue | AUD 5.33M |
| Growth | +499.2% |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Atomo Diagnostics Limited. Atomo Diagnostics Limited has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| CBL.AXControl Bionics Limited | Healthcare | Medical - Devices | — | ||
| ENL.AXEnlitic, Inc. | Healthcare | Medical - Healthcare Information Services | — | ||
| HMD.AXHeraMED Limited | Healthcare | Medical - Devices | — | ||
| IDT.AXIDT Australia Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| IMC.AXImmuron Limited | Healthcare | Biotechnology | — | ||
| NTI.AXNeurotech International Limited | Healthcare | Biotechnology | — | ||
| OSL.AXOncoSil Medical Ltd | Healthcare | Medical - Devices | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
| CLPTClearPoint Neuro, Inc. | Healthcare | NASDAQ | $247.1M | ||
| CLVSFCellaVision AB (publ) | Healthcare | OTC | $378.0M | ||
| CMP.AXCompumedics Limited | Healthcare | ASX | — | ||
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
| CNVIFConavi Medical Corp. | Healthcare | OTC | $20.7M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Atomo Diagnostics Limited. Coverage tracks Atomo Diagnostics Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Atomo Diagnostics Limited.